Contineum Therapeutics, Inc. Class A Common Stock

NASDAQ:CTNM

Biotechnology

Healthcare
$9.24 -3.20%

-$0.39 today

Market cap
$326.66M
Beta
0.89
P/E (TTM)
-7.5
EPS (TTM)
-$1.57
52W Low $3.69High $16.33

Volume 0.20M

Average 0.26M

Price history

Contineum Therapeutics, Inc. Class A Common Stock SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-25.66%

Period high

$17.57

Period low

$7.08

Latest

$9.24

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13G/ANov 6, 2026Nov 6, 2026
SC 13GNov 5, 2026Nov 5, 2026
10-QNov 3, 2026Nov 3, 2026
8-KNov 3, 2026Nov 3, 2026
SC 13GOct 28, 2026Oct 28, 2026
SC 13G/AOct 28, 2026Oct 28, 2026
SC 13GOct 22, 2026Oct 22, 2026
8-KSep 14, 2026Sep 14, 2026
4Sep 8, 2026Sep 8, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
4Aug 3, 2026Aug 3, 2026
10-QJul 30, 2026Jul 30, 2026
8-KJul 30, 2026Jul 30, 2026
SC 13GJul 27, 2026Jul 27, 2026
SC 13G/AJul 17, 2026Jul 17, 2026

Competitors

Who does Contineum Therapeutics, Inc. Class A Common Stock compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about CTNM's filings, answered from its disclosures.

What is the latest CTNM filing?

The latest filing shown is SC 13G/A dated Nov 6, 2026.

How many recent filings does CTNM have?

Intrinsic Alpha currently shows 20 recent filings for CTNM.